BioTuesdays

Category - Markets

Translate Bio Logo
Markets

HCW starts Translate Bio at buy; PT $21

H.C. Wainwright initiated coverage of Translate Bio (NASDAQ:TBIO) with a “buy” rating and $21 price target. The stock closed at $8.05 on Dec. 24. Translate Bio is developing treatments for diseases caused by an absence...

December 24, 2018
AnaptysBio
Markets

HCW starts AnaptysBio at buy; PT $126

H.C. Wainwright initiated coverage of AnaptysBio (NASDAQ:ANAB) with a “buy” rating and price target of $126. The stock closed at $60.54 on Dec. 19. While AnaptysBio has emerged as a newcomer in the competitive field of...

December 21, 2018
Dova Pharmaceuticals
Markets

HCW starts Dova Pharma at buy; PT $18

H.C. Wainwright initiated coverage of Dova Pharmaceuticals (NASDAQ:DOVA) with a “buy” rating and price target of $18. The stock closed at $5.73 on Dec.19. Dova is developing a new thrombopoietin receptor alpha agonist...

December 21, 2018
DBV Technologies
Markets

Stifel cuts DBV Technologies to hold; PT $11

Stifel downgraded DBV Technologies (NASDAQ:DBVT) to “hold” from “buy” and slashed its price target to $11 from $35 after the company withdrew the BLA for its Viaskin peanut allergy treatment after a meeting with the FDA...

December 20, 2018
Brainstorm Cell Therapeutics Logo
Markets

Dawson James starts Brainstorm at buy; PT $12

Dawson James initiated coverage of Brainstorm (NASDAQ:BCLI) with a “buy” rating and $12 price target. The stock closed at $3.05 on Dec. 17. Brainstorm uses autologous cell therapy to treat amyotrophic lateral sclerosis...

December 18, 2018